Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector

Posted: 29 Jul 2009

See all articles by Suma Athreye

Suma Athreye

Brunel University London - Brunel Business School

Dinar Kale

Open University, UK

Shyama Ramani

affiliation not provided to SSRN

Date Written: August 2009

Abstract

This article demonstrates that radical regulatory changes can be tantamount to technological revolutions by studying Indian pharmaceutical firms. It shows that radical regulatory changes such as the Indian Patent Act of 1970, the New Industrial Policy of 1991 and the signing of TRIPS (Trade Related Intellectual Property Rights System) in 1995 served to open up new economic opportunities and constraints in the wake of which the winners and losers were selected as a function of the dynamic firm capabilities most appropriate for the new market environment.

Suggested Citation

Athreye, Suma S. and Kale, Dinar and Ramani, Shyama, Experimentation with Strategy and the Evolution of Dynamic Capability in the Indian Pharmaceutical Sector (August 2009). Industrial and Corporate Change, Vol. 18, Issue 4, pp. 729-759, 2009. Available at SSRN: https://ssrn.com/abstract=1440070 or http://dx.doi.org/dtp024

Suma S. Athreye (Contact Author)

Brunel University London - Brunel Business School ( email )

Kingston Lane
Eastern Gateway Building
Uxbridge, Middlesex UB8 3PH
United Kingdom

Dinar Kale

Open University, UK ( email )

Walton Hall
Milton Keynes, Buckinghamshire MK7 6AA
United Kingdom

Shyama Ramani

affiliation not provided to SSRN ( email )

Register to save articles to
your library

Register

Paper statistics

Abstract Views
282
PlumX Metrics